INKTMiNK Therapeutics, Inc.May 15, 2026Q1 2026
Read transcript →MiNK Therapeutics, Inc. (INKT) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$11.87
+0.51%
Mkt Cap $55.32M
INKTMiNK Therapeutics, Inc.May 15, 2026INKTMiNK Therapeutics, Inc.Mar 31, 2026Q4 2025
Read transcript →INKTMiNK Therapeutics, Inc.Nov 14, 2025Q3 2025
Read transcript →INKTMiNK Therapeutics, Inc.Aug 14, 2025Q2 2025
Read transcript →INKTMiNK Therapeutics, Inc.May 15, 2025Q1 2025
Read transcript →INKTMiNK Therapeutics, Inc.Mar 18, 2025Q4 2024
Read transcript →INKTMiNK Therapeutics, Inc.Nov 14, 2024Q3 2024
Read transcript →INKTMiNK Therapeutics, Inc.Aug 13, 2024Q2 2024
Read transcript →INKTMiNK Therapeutics, Inc.May 14, 2024Q1 2024
Read transcript →INKTMiNK Therapeutics, Inc.Mar 21, 2024Q4 2023
Read transcript →INKTMiNK Therapeutics, Inc.Nov 9, 2023Q3 2023
Read transcript →INKTMiNK Therapeutics, Inc.May 14, 2023Q1 2023
Read transcript →INKTMiNK Therapeutics, Inc.Mar 21, 2023Q4 2022
Read transcript →INKTMiNK Therapeutics, Inc.Nov 6, 2022Q3 2022
Read transcript →INKTMiNK Therapeutics, Inc.Aug 13, 2022Q2 2022
Read transcript →